Nutex Health (NASDAQ:NUTX) Trading 1.1% Higher – Should You Buy?

Shares of Nutex Health Inc. (NASDAQ:NUTX) traded up 1.1% during mid-day trading on Thursday . The company traded as high as $151.00 and last traded at $149.10. Approximately 77,009 shares traded hands during trading, a decline of 37% from the average daily volume of 122,047 shares. The stock had previously closed at $147.54.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on NUTX shares. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Lake Street Capital initiated coverage on Nutex Health in a research report on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price objective for the company. Finally, Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Nutex Health currently has an average rating of “Moderate Buy” and a consensus price target of $220.00.

Nutex Health Trading Up 1.1%

The company has a current ratio of 3.14, a quick ratio of 3.12 and a debt-to-equity ratio of 0.66. The business’s fifty day simple moving average is $128.09 and its two-hundred day simple moving average is $130.09. The stock has a market capitalization of $1.03 billion, a P/E ratio of 11.52 and a beta of 0.26.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $6.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.99 by $2.53. The company had revenue of $216.49 million for the quarter, compared to the consensus estimate of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of NUTX. Deutsche Bank AG boosted its stake in Nutex Health by 3.9% during the fourth quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock worth $433,000 after buying an additional 98 shares in the last quarter. Russell Investments Group Ltd. raised its stake in shares of Nutex Health by 1.4% in the 4th quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock valued at $1,433,000 after buying an additional 116 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al raised its stake in shares of Nutex Health by 3.7% in the 4th quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,600 shares of the company’s stock valued at $922,000 after buying an additional 200 shares in the last quarter. Islay Capital Management LLC bought a new position in shares of Nutex Health during the 4th quarter worth about $34,000. Finally, First Trust Advisors LP boosted its position in shares of Nutex Health by 2.4% during the 4th quarter. First Trust Advisors LP now owns 11,461 shares of the company’s stock valued at $1,887,000 after acquiring an additional 272 shares in the last quarter. 5.32% of the stock is owned by institutional investors.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.